Therefore, according to our results, the interaction between central obesity and hypertension may lead to a reduction in anti-inflammatory adipokines, adiponectin, and further increases in pro-inflammatory adipokines and TNF-α compared with female subjects with central obesity or hypertension alone. This evidence concerns the gene ADIPOQ and Abdominal obesity.